About Pantoprazole Sodium API
Therapeutic CategoryGastro-Intestinal - GI

CAS Number
164579-32-2
API Technology
Synthetic
Dose Form
Suspension, Tablets, Injectable
Dr Reddy's Development Status
Available
Available Regulatory Filing
USDMF, CEP Submitted, Brazil DMF, EUDMF, Canada DMF, Japan DMF, China DMF
Mechanism of Action
Pantoprazole is a PPI that suppresses the final step in gastric acid production by covalently binding to the (H+, K+)-ATPase enzyme system at the secretory surface of the gastric parietal cell. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. The binding to the (H+, K+)-ATPase results in a duration of antisecretory effect that persists longer than 24 hours for all doses tested (20 mg to 120 mg).
Indication
PROTONIX is a proton pump inhibitor (PPI) indicated for the following:
- Short-Term Treatment of Erosive Esophagitis Associated with Gastroesophageal Reflux Disease (GERD)
- Maintenance of Healing of Erosive Esophagitis
- Pathological Hypersecretory Conditions Including Zollinger-Ellison (ZE) Syndrome
Related APIs
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!
FAQs
Treats GERD, erosive esophagitis, and Zollinger-Ellison syndrome
Available as delayed-release tablets (20 mg, 40 mg) and injection (40 mg)
Reduces stomach acid production
Alleviates heartburn and acid reflux symptoms
Promotes healing of esophageal damage
Store at 20°C to 25°C (68°F to 77°F), in a cool, dry place, away from moisture and light
Disclaimer
No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.